Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9433)
All Articles published online
|
Publishing Process of This Article
|
Dec 9, 2014 (publication date) through Jun 26, 2024
Times Cited of This Article
- Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Pharmacology
ISSN
2220-3192
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
2018 | Number of total visits
| Rank | Countries/Territories | Count | Percent |
| 1 | United States | 192 | 40.4% |
| 2 | 52 | 10.9% | |
| 3 | India | 52 | 10.9% |
| 4 | China | 39 | 8.2% |
| 5 | Germany | 19 | 4% |
| 6 | Egypt | 9 | 1.9% |
| 7 | France | 9 | 1.9% |
| 8 | Finland | 8 | 1.7% |
| 9 | Australia | 8 | 1.7% |
| 10 | Canada | 7 | 1.5% |
| 11 | Indonesia | 7 | 1.5% |
| 12 | United Kingdom | 7 | 1.5% |
| 13 | Ireland | 5 | 1.1% |
| 14 | Nigeria | 5 | 1.1% |
| 15 | Pakistan | 5 | 1.1% |
| 16 | Malaysia | 5 | 1.1% |
| 17 | Slovakia | 4 | 0.8% |
| 18 | Japan | 4 | 0.8% |
| 19 | Austria | 3 | 0.6% |
| 20 | Netherlands | 3 | 0.6% |
| 21 | Turkey | 2 | 0.4% |
| 22 | Brazil | 2 | 0.4% |
| 23 | Ethiopia | 2 | 0.4% |
| 24 | Republic of Korea | 2 | 0.4% |
| 25 | Sri Lanka | 2 | 0.4% |
| 26 | Syria | 2 | 0.4% |
| 27 | Mexico | 2 | 0.4% |
| 28 | Russia | 2 | 0.4% |
| 29 | Saudi Arabia | 1 | 0.2% |
| 30 | Singapore | 1 | 0.2% |
| 31 | Taiwan | 1 | 0.2% |
| 32 | Slovenia | 1 | 0.2% |
| 33 | South Africa | 1 | 0.2% |
| 34 | Romania | 1 | 0.2% |
| 35 | Kenya | 1 | 0.2% |
| 36 | Lebanon | 1 | 0.2% |
| 37 | Iraq | 1 | 0.2% |
| 38 | Greece | 1 | 0.2% |
| 39 | Hong Kong | 1 | 0.2% |
| 40 | Bulgaria | 1 | 0.2% |
| 41 | Chile | 1 | 0.2% |
| 42 | Belarus | 1 | 0.2% |
| 43 | Belgium | 1 | 0.2% |
| 44 | United Arab Emirates | 1 | 0.2% |